Afatinib Terminated Phase 2 Trials for Breast Cancer Metastatic Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01531764BIBW 2992 (Afatinib) and Vinorelbine